Half of Pakistani adults have it. Six percent are controlled. That gap, not the choice of fourth-line agent, is what this pathway is about.
This is a real national guideline, and it is current. The 4th National Hypertension Guidelines were published in 2023 as a peer-reviewed supplement to the Journal of the Pakistan Medical Association, produced by the Pakistan Hypertension League and endorsed by the Pakistan Cardiac Society. It is the fourth update of a document first written in 1998.
Same as international guidelinePakistan-adaptedLocal data onlyNational guideline outdated
Disclosure, because you should weigh it. For transparency: the guideline states it was produced in collaboration with Getz Pharma, and the published PDF carries antihypertensive brand advertising. Peer review and Cardiac Society endorsement count against that, but you should know it when reading drug-class recommendations.
Decision-support only, and note the scope. Adults. Confirming the diagnosis, targets, initial drug choice and the practices the guideline says to stop. Secondary hypertension workup, hypertension in pregnancy and paediatric hypertension are out of scope — the Pakistan Hypertension League publishes separate paediatric guidance.
✓ Clinically reviewed by Dr Soban Bin Salman Meer, MBBS · 05 Aug 2026.
Step 1 · The problem is not which drug
Pakistani epidemiology
Six percent Local data only
Every other adult you see may be hypertensive, and roughly one in sixteen of those is controlled. That cascade — not the choice between a third and fourth agent — is the clinical problem in Pakistan.
Prevalence in adults
50%
50% in the 2014–15 survey, 46% in 2016–17
Aware they have it
30%
Seven in ten do not know
On treatment
18%
Fewer than one in five
Controlled
6%
Six in a hundred
What follows from that. It follows that opportunistic measurement, correct measurement technique, and anything that improves adherence will do more good than refining the regimen of the small minority already treated.
There are no symptoms to prompt you Same as international guideline
There are no usual signs and symptoms of Hypertension and therefore it is called the "silent killer".
With awareness at 30%, the patient in front of you for something else is the main opportunity for detection. Symptoms appear with the complications, which is too late to be useful as a trigger.
Step 2 · Confirm before you label
4th National Hypertension Guidelines
Confirming the diagnosis — the thresholds differ by method Same as international guideline
Method
Diagnostic threshold
Note
Repeat office BP
Average of 3 readings above 160/110, or BP above 140/90 averaged across 5 visits
One high reading is not a diagnosis.
Home BP monitoring (HBPM)
Systolic 135 mmHg or above, or diastolic 85 mmHg or above
If the average home BP is below 135/85, repeat home monitoring to confirm, or perform ambulatory monitoring.
Ambulatory BP (ABPM)
Above 130/80 overall, or above 135/85 daytime
The reference method where home readings and office readings disagree.
Where there is no macrovascular disease, diabetes or chronic kidney disease and the systolic is below 180 and diastolic below 110, the guideline directs further evaluation at a subsequent visit rather than immediate treatment.
The measurement problem that is specific to here Pakistan-adapted
The guideline recommends a validated digital device for home monitoring. The practical obstacle in Pakistan is that a large number of non-validated monitors are on the market, alongside limited physician familiarity with home-monitoring methodology and the cost of the device itself. A home reading from an unvalidated machine is not the test the guideline is describing.
In practice. If you are going to rely on home readings, check the device against a validated list, and check the patient's technique — seated rest, correct cuff size, arm supported at heart level, and an average of readings rather than a single one.
Why it is flagged: International guidelines assume access to validated devices. That assumption does not hold in a market with a large number of unvalidated monitors.
Baseline investigations
Lipid profile
Urine detailed report
Electrocardiogram
Estimated GFR
And use the Pakistani eGFR equation. The guideline specifies that eGFR should be calculated using the CKD-EPI Pak equation, referencing Jessani et al., American Journal of Kidney Diseases 2014. Equations calibrated on European and North American cohorts misestimate GFR in South Asian populations, which matters when kidney disease is one of the things that shifts the BP target. Pakistan-adapted
Step 3 · Which target for this patient
4th National Hypertension Guidelines
A three-tier target, and it is staged Pakistan-adapted
The guideline sets a primary target that everyone should reach and a secondary, tighter target for those who can tolerate it — rather than a single blanket number. In a country with 6% control, getting patients to the first target is the work.
The guideline notes that JNC 8, ESC, BHS, CHEP and others have historically used 140/90 as the treatment threshold; ESC 2018 recommended reaching 130/80 where possible after achieving 140/90; and the AHA 2017 guidelines lowered the diagnostic threshold to 130/80 — a figure the guideline observes is above the threshold used in SPRINT, the trial that underpins it. It also notes SPRINT used research-grade measurement: five minutes of seated rest in a quiet room, correct cuff application, and three averaged readings from an automated device.
Why it is flagged: The three-tier staged target, including a distinct and more permissive target for the over-80s, is the national position and differs from a blanket 130/80.
Step 4 · What to start
4th National Hypertension Guidelines
A-C-D-S Same as international guideline
The guideline follows an algorithmic A-C-D-S approach — ACE inhibitor or ARB, calcium channel blocker, diuretic, then a spironolactone-type agent — having moved on from the older ABCD sequence. Real-world Pakistani prescribing runs calcium channel blockers at 61%, beta-blockers at 49% and ARBs at 47%.
Single-pill combinations, because adherence is the bottleneck Pakistan-adapted
The guideline reports that initiating a single-pill fixed-dose combination was associated with better adherence than diuretic monotherapy, that adherence increases with fixed-dose combinations generally, and that adherence to a fixed-dose combination of a calcium channel blocker with an ACE inhibitor was significantly greater than the same drugs given separately.
Why this matters more here. With control at 6% and cost a documented barrier, a once-daily single pill is not a convenience — it is the intervention most likely to move the number. It also reduces the total dispensing cost in an out-of-pocket system.
Where the comorbidity picks the drug Same as international guideline
When hypertension coexists with a condition that compels a particular agent, the ordinary sequence is overridden. The guideline gives heart failure — diuretics, beta-blockers, ARNI or ACE inhibitors/ARBs, and an aldosterone antagonist — and post-myocardial infarction, where beta-blockers move to first line, as its worked examples.
Cost is clinical. Cost is a documented barrier to adherence, and the guideline literature notes that traditional medicine remains popular in Pakistan partly because it is more accessible and less expensive than conventional antihypertensives. A regimen the patient cannot sustain is not a regimen.
Refractory hypertension: Refractory hypertension is defined as uncontrolled BP despite five or more antihypertensive agents of different classes, including a long-acting thiazide-like diuretic and a mineralocorticoid receptor antagonist, at maximal or maximally tolerated doses.
Step 5 · Two things to stop doing
4th National Hypertension Guidelines — special concerns
Two practices the national guideline explicitly tells you to stop. Both have dedicated sections in the national guideline, which tells you how common they are.
✕ Sublingual nifedipine or captopril to drop a high reading Pakistan-adapted
For severe hypertension above 180/120 without symptoms, with or without chronic hypertension-mediated organ damage, the guideline states the use of sublingual drugs is contraindicated. Sublingual nifedipine is no longer recommended because of its propensity to cause severe hypotension.
Why: Bringing the BP down sharply is itself discouraged — a sharp decrease may cause hypoperfusion and loss of consciousness, ischaemic stroke and myocardial infarction. A high number in an asymptomatic patient is not an emergency to be corrected in the clinic.
✕ Anxiolytics as antihypertensive therapy Pakistan-adapted
The guideline devotes a section to the practice of using anxiolytics to treat hypertension, noting it has been in vogue. Benzodiazepine use in Pakistan has been observed to be higher than in other developing countries, largely because of over-the-counter availability, with only a small fraction of patients consulting a psychiatrist.
Why: A benzodiazepine lowers the reading in the room without treating the disease, and creates a dependence problem on top of an untreated cardiovascular one. That the national guideline needed a dedicated section on this says something about how common it is.
Step 6 · What actually moves the number
Synthesis
What actually moves the 6% Local data only
Measure opportunistically. With awareness at 30%, the consultation for something else is where most undiagnosed hypertension will be found.
Measure properly — seated rest, correct cuff size, arm at heart level, averaged readings. The guideline's own targets are built on research-grade measurement.
Confirm before labelling. One high reading in clinic is not hypertension, and a wrongly labelled patient is a patient on lifelong medication they did not need.
Prefer a single-pill combination where one is available and affordable. It is the intervention with the clearest adherence evidence in the guideline.
Ask what the regimen costs the patient each month, and ask it out loud. Cost is a documented reason people stop, and traditional remedies are cheaper and more available.
Check the home monitor is validated before trusting its readings.
Get to 140/90 first. The tighter target is a second stage for those who tolerate it, not the opening position.
Common questions
What is the blood pressure target in Pakistan?
The 4th National Hypertension Guidelines set three staged targets: below 140/90 as the primary target everyone other than the elderly should achieve, below 130/80 as a secondary target most non-frail, non-elderly patients can reach after that, and below 150/90 for most people over 80.
Should I aim for 130/80 in everyone?
No. The national guideline frames 130/80 as a second stage after reaching 140/90, not as the opening position — and sets a more permissive 150/90 for patients over 80. Chasing 130/80 in a frail 85-year-old is not what the guideline asks for.
How many readings confirm hypertension?
An average of three readings above 160/110, or blood pressure above 140/90 averaged across five visits. On home monitoring, systolic 135 or above or diastolic 85 or above. On ambulatory monitoring, above 130/80 overall or above 135/85 daytime. One high reading in clinic is not a diagnosis.
Can I use sublingual nifedipine to bring down a very high reading?
No. For severe hypertension above 180/120 without symptoms, the guideline states sublingual drugs are contraindicated, and sublingual nifedipine is no longer recommended because it causes severe hypotension. Sharp reduction is itself discouraged — it risks hypoperfusion, loss of consciousness, ischaemic stroke and myocardial infarction.
Are anxiolytics an acceptable treatment for hypertension?
No, and the national guideline has a dedicated section on it because the practice is common here. Pakistani benzodiazepine use is higher than in other developing countries, largely because of over-the-counter availability, with only a small fraction of patients seeing a psychiatrist. A benzodiazepine lowers the reading in the room without treating the disease.
Which eGFR equation should I use?
The guideline specifies the CKD-EPI Pak equation, referencing Jessani et al. in the American Journal of Kidney Diseases. Equations calibrated on European and North American cohorts misestimate GFR in South Asians, which matters because kidney disease shifts the blood pressure target.
Why prefer a single-pill combination?
Adherence. The guideline reports better adherence with fixed-dose combinations than with monotherapy, and significantly better adherence to a calcium channel blocker plus ACE inhibitor given as one pill than as two. With control at 6% and cost a documented barrier, adherence is the bottleneck.
How well controlled is hypertension in Pakistan?
Prevalence is 46 to 50% of adults. Awareness is 30%, treatment 18%, and control 6%. Roughly one in sixteen hypertensive Pakistanis has controlled blood pressure.
Clinically reviewed by Dr Soban Bin Salman Meer, MBBS
MBBS — Postgraduate Trainee in the Department of Urology at the Pakistan Institute of Medical Sciences (PIMS), Islamabad. Graduated from Federal Medical & Dental College, Islamabad.
Sources
Khan AH, Almas A, Shahab H, Ishaq M, Mohsin S, Memon F, et al. 4th National Hypertension Guidelines. Journal of the Pakistan Medical Association 2023;73(Supplement 7):S1-78. Pakistan Hypertension League, endorsed by the Pakistan Cardiac Society. The fourth update of a national guideline first produced in 1998, and the source of every threshold, target and quoted recommendation on this page.
DISCLOSURE: the guideline states it was produced in collaboration with Getz Pharma, and the published supplement carries antihypertensive brand advertising. It is nonetheless peer-reviewed in an indexed journal and endorsed by the Pakistan Cardiac Society.
Siddique S, et al. Asian management of hypertension: current status, home blood pressure, and specific concerns in Pakistan. Journal of Clinical Hypertension, 2020 — source of the prevalence, awareness, treatment and control figures, the real-world prescribing pattern, and the non-validated device and traditional medicine observations.
Jessani S, et al. American Journal of Kidney Diseases 2014;1:49-58 — the CKD-EPI Pak equation the guideline specifies for estimating GFR.
The 3rd National Hypertension Guideline (Pakistan Hypertension League, 2018) remains available and was used to check what changed between editions.
SCOPE NOTE: adults only. Secondary hypertension workup, hypertension in pregnancy and paediatric hypertension are out of scope; the PHL publishes separate paediatric guidance.
Background reading — where the 6% goes, why 130/80 is a second stage rather than a starting point, and the two practices to stop: hypertension in Pakistan.